文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中国南方帕金森病患者的肠道微生物群。

Gut microbiota in patients with Parkinson's disease in southern China.

机构信息

Department of Neurology, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue Middle, Guangzhou City, Guangdong Province, 510282, PR China.

State Key Laboratory of Organ Failure Research, Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue Middle, Guangzhou City, Guangdong Province, 510282, PR China.

出版信息

Parkinsonism Relat Disord. 2018 Aug;53:82-88. doi: 10.1016/j.parkreldis.2018.05.007.


DOI:10.1016/j.parkreldis.2018.05.007
PMID:29776865
Abstract

INTRODUCTION: Accumulating evidence has revealed alterations in the communication between the gut and brain in patients with Parkinson's disease (PD), and previous studies have confirmed that alterations in the gut microbiome play an important role in the pathogenesis of numerous diseases, including PD. The aim of this study was to determine whether the faecal microbiome of PD patients in southern China differs from that of control subjects and whether the gut microbiome composition alters among different PD motor phenotypes. METHODS: We compared the gut microbiota composition of 75 patients with PD and 45 age-matched controls using 16S rRNA next-generation-sequencing. RESULTS: We observed significant increases in the abundance of four bacterial families and significant decreases in the abundance of seventeen bacterial families in patients with PD compared to those of the controls. In particular, the abundance of Lachnospiraceae was reduced by 42.9% in patients with PD, whereas Bifidobacteriaceae was enriched in patients with PD. We did not identify a significant difference in the overall microbial composition among different PD motor phenotypes, but we identified the association between specific taxas and different PD motor phenotypes. CONCLUSIONS: PD is accompanied by alterations in the abundance of specific gut microbes. The abundance of certain gut microbes was altered depending on clinical motor phenotypes. Based on our findings, the gut microbiome may be a potential PD biomarker.

摘要

简介:越来越多的证据表明,帕金森病(PD)患者的肠道与大脑之间的通讯发生了改变,先前的研究已经证实,肠道微生物组的改变在许多疾病的发病机制中起着重要作用,包括 PD。本研究旨在确定中国南方 PD 患者的粪便微生物组是否与对照组不同,以及肠道微生物组组成是否在不同 PD 运动表型之间发生改变。

方法:我们使用 16S rRNA 下一代测序比较了 75 例 PD 患者和 45 名年龄匹配的对照者的肠道微生物组成。

结果:与对照组相比,PD 患者的四种细菌家族的丰度显著增加,十七种细菌家族的丰度显著降低。特别是,PD 患者的lachnospiraceae 的丰度降低了 42.9%,而 bifidobacteriaceae 在 PD 患者中富集。我们没有发现不同 PD 运动表型之间整体微生物组成存在显著差异,但我们发现了特定分类群与不同 PD 运动表型之间的关联。

结论:PD 伴有特定肠道微生物丰度的改变。某些肠道微生物的丰度根据临床运动表型而改变。基于我们的发现,肠道微生物组可能是 PD 的一个潜在生物标志物。

相似文献

[1]
Gut microbiota in patients with Parkinson's disease in southern China.

Parkinsonism Relat Disord. 2018-8

[2]
Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.

Neurosci Lett. 2019-6-11

[3]
Gut microbiota are related to Parkinson's disease and clinical phenotype.

Mov Disord. 2015-3

[4]
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.

Mov Disord. 2017-8-26

[5]
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.

Mov Disord. 2017-5

[6]
Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.

Biomolecules. 2021-1-22

[7]
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.

J Neuroinflammation. 2019-6-27

[8]
Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.

Parkinsonism Relat Disord. 2020-12

[9]
Dysbiosis of gut microbiota in a selected population of Parkinson's patients.

Parkinsonism Relat Disord. 2019-6-3

[10]
Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.

Sci China Life Sci. 2017-5-20

引用本文的文献

[1]
Gut dysbiosis as a potential driver of Parkinson's and Alzheimer's disease pathogenesis.

Front Neurosci. 2025-8-13

[2]
Microbial diversity in drug-naïve Parkinson's disease patients.

PLoS One. 2025-8-18

[3]
Effect of Probiotics Supplementation on REM Sleep Behavior Disorder and Motor Symptoms in Parkinson's Disease: A Pilot Study.

CNS Neurosci Ther. 2025-7

[4]
Proinflammatory and GABA eating bacteria in Parkinson's disease gut microbiome from a meta-analysis prospective.

NPJ Parkinsons Dis. 2025-6-3

[5]
Recent advances in therapeutic probiotics: insights from human trials.

Clin Microbiol Rev. 2025-6-12

[6]
How gut microbes affect Parkinson's disease: an editorial.

Ann Med Surg (Lond). 2025-3-27

[7]
FLZ attenuates Parkinson's disease pathological damage by increasing glycoursodeoxycholic acid production down-regulating .

Acta Pharm Sin B. 2025-2

[8]
The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson's disease.

Neurol Sci. 2025-3-14

[9]
Gut microbiota: A new window for the prevention and treatment of neuropsychiatric disease.

J Cent Nerv Syst Dis. 2025-2-21

[10]
Repetitive transcranial magnetic stimulation improves cognition, depression, and walking ability in patients with Parkinson's disease: a meta-analysis.

BMC Neurol. 2024-12-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索